- Home
- REPL vs EVTL Comparison
REPL vs EVTL Comparison
Compare REPL & EVTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- EVTL
- Stock Information
- Founded
- REPL 2015
- EVTL 2016
- Country
- REPL United States
- EVTL United Kingdom
- Employees
- REPL N/A
- EVTL N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- EVTL Aerospace
- Sector
- REPL Health Care
- EVTL Industrials
- Exchange
- REPL Nasdaq
- EVTL Nasdaq
- Market Cap
- REPL 547.0M
- EVTL 444.1M
- IPO Year
- REPL 2018
- EVTL N/A
- Fundamental
- Price
- REPL $5.80
- EVTL $5.32
- Analyst Decision
- REPL Hold
- EVTL Strong Buy
- Analyst Count
- REPL 9
- EVTL 7
- Target Price
- REPL $7.00
- EVTL $10.83
- AVG Volume (30 Days)
- REPL 2.5M
- EVTL 876.9K
- Earning Date
- REPL 11-11-2025
- EVTL 08-05-2025
- Dividend Yield
- REPL N/A
- EVTL N/A
- EPS Growth
- REPL N/A
- EVTL N/A
- EPS
- REPL N/A
- EVTL N/A
- Revenue
- REPL N/A
- EVTL N/A
- Revenue This Year
- REPL N/A
- EVTL N/A
- Revenue Next Year
- REPL $408.25
- EVTL N/A
- P/E Ratio
- REPL N/A
- EVTL N/A
- Revenue Growth
- REPL N/A
- EVTL N/A
- 52 Week Low
- REPL $2.68
- EVTL $2.76
- 52 Week High
- REPL $17.00
- EVTL $15.99
- Technical
- Relative Strength Index (RSI)
- REPL 47.90
- EVTL 54.05
- Support Level
- REPL $5.74
- EVTL $4.90
- Resistance Level
- REPL $6.15
- EVTL $5.17
- Average True Range (ATR)
- REPL 0.35
- EVTL 0.30
- MACD
- REPL 0.12
- EVTL 0.08
- Stochastic Oscillator
- REPL 41.03
- EVTL 92.25
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About EVTL Vertical Aerospace Ltd.
Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero operating emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.